ZYS-10112-91460 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-05
Registered in v-safe
2021-01-05
Dose 1 — Moderna
2021-01-05
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness, Swelling · None

Adult check-in
2021-01-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Redness, Swelling · None

Adult check-in
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-12
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-21
Survey response — day 14, dose 1
MedDRA: Injection site erythema, Injection site swelling — Feeling: Good

Free text: The injection site became swollen and red again.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-26
Survey response — day 21, dose 1
MedDRA: Petechiae — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: The petechiae rash that appeared approximately 2 days after the 1st dose continues to spread but isnt causing any discomfort.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-26
Report sent to call center — day 21, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-30
Dose 2 — Moderna
2021-02-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness, Swelling · Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Adult check-in
2021-02-02
Report sent to call center — days 1–6 daily, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-03
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site

Adult check-in
2021-02-04
Survey response — days 1–6 daily, dose 2
MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection site

Free text: Rash continues to spread slowly. It covers about 50% of my body.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Rash, not including the immediate area around the injection site

Adult check-in
2021-02-06
Health check-in — day 7, dose 2
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-02-13
Survey response — day 14, dose 2
MedDRA: Exfoliative rash, Medical counselling, Rash — Feeling: Good

Free text: Rash (that is separate from the injection site) continues to spread and change of skin texture (small bumps and scaly) noted. I sought medical advice for this and have seen 2 physicians who were unable to diagnose this condition.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-22
Survey response — day 21, dose 2
MedDRA: Rash — Feeling: Good

Free text: Full body rash continues to spread

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-01
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-06
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-13
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-12
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-05	Moderna
2	2021-01-30	Moderna

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 2 — day 14, dose 1

2021-01-21

Symptoms: The injection site became swollen and red again.

Release 2 — day 21, dose 1

2021-01-26

Symptoms: The petechiae rash that appeared approximately 2 days after the 1st dose continues to spread but isnt causing any discomfort.

Release 3 — days 1–6 daily, dose 2

2021-02-04

Systemic reaction (other): Rash continues to spread slowly. It covers about 50% of my body.

Release 4 — day 14, dose 2

2021-02-13

Symptoms: Rash (that is separate from the injection site) continues to spread and change of skin texture (small bumps and scaly) noted. I sought medical advice for this and have seen 2 physicians who were unable to diagnose this condition.

Release 4 — day 21, dose 2

2021-02-22

Symptoms: Full body rash continues to spread

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Exfoliative rash	✓	✓	✓
SD	Injection site erythema	✓	✓	✓
SD	Injection site swelling	✓	✓	✓
SD	Medical counselling	✓	✓	✓
SD	Petechiae	✓	✓	✓
SD	Rash	✓	✓	✓
SRO	Rash	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release